Global Rabies Diagnostics Market
Veterinary Healthcare

What Will The Rabies Diagnostics Market Look Like In 2023?

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s rabies diagnostics market report forecasts the rabies diagnostics market size to grow to to $2.01 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Rabies Diagnostics Market Report 2023 –

Rabies Diagnostics Market Size Forecast
The global rabies diagnostics market is expected to grow from $1.51 billion in 2022 to $1.60 billion in 2023 at a compound annual growth rate (CAGR) of 6.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The rabies diagnostics market size is expected to grow to $2.01 billion in 2027 at a CAGR of 5.8%.

North America held the largest rabies diagnostics market share.

Key Rabies Diagnostics Market Driver ­– Increase In The Prevalence Of Rabies
For instance, in May 2021, according to the report published by the World Health Organization, a Switzerland-based agency for international public health states that every year, rabies kills around 59,000 people globally, and more than 29 million people worldwide receive a post-bite vaccine. Rabies is estimated to cost the world $8.6 billion each year. Therefore, the increasing prevalence of rabies will drive the rabies diagnostics market.

Request for A Sample Of The Global Rabies Diagnostics Market Report:

Key Rabies Diagnostics Market Trend – Product Innovation
Innovation and development of efficient testing techniques in the field of analytical chemistry designed to provide accurate and cost-effective analytical solutions are being adopted by pharmaceutical manufacturers all around the globe. These testing products are efficiently integrated into the regular sample testing process. For instance, in May 2022, Bio-Rad Laboratories Inc., a US-based developer, and manufacturer of specialized technology products launched the CFX Duet Real-Time PCR system, a clinical diagnostic device designed to aid researchers in the development of singleplex and duplex quantitative PCR (qPCR) tests. The unique features of the product provide improved thermal performance, as well as a patented, precise optical shuttle system and thermal gradient functionality for optimization.

Rabies Diagnostics Market Segment
1) By Diagnostic Method: Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
2) By Technology: ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
3) By End-User: Hospital, Diagnostic Centres, Cancer Palliative Care Clinics, Other End-Users

Rabies Diagnostics Market Major Players and Strategies
Major players in the rabies diagnostics market are Bio-Rad Laboratories Inc., Merck KGaA, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Thermo Fisher Scientific Inc. and Fluidigm Corp.

In December 2021, Co-Diagnostics, Inc., a US-based diagnostics test company acquired Idaho Molecular Inc. and Advanced Conceptions Inc. for an undisclosed amount. With this acquisition of Idaho Molecular Inc. and Advanced Conceptions Inc., Co-Diagnostics strengthened its position in the market as it takes this step towards the next phase of growth focused on making this next-generation healthcare solution available worldwide. Idaho Molecular Inc. and Advanced Conceptions, Inc. are a US-based companies that provide diagnostic and therapeutic devices operating in the rabies diagnostics market.

The Rabies Diagnostics Global Market Report 2023 covers regional data on rabies diagnostics market size, rabies diagnostics market trends and drivers, opportunities, strategies, and rabies diagnostics market competitor analysis. The countries covered in the rabies diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Rabies diagnostics refers to the process of identifying Rabies disease based on the condition and symptoms. It is a preventable viral illness that is most commonly spread via a rabid animal’s bite. Rabies can be diagnosed once the rabies virus is found in any portion of the infected animal’s brain. In humans, saliva, serum, spinal fluid, and skin biopsies of hair follicles at the nape of the neck are tested for diagnosis.

View More Reports Related To The Rabies Diagnostics Market –
Point-Of-Care Diagnostics Devices And Equipment Global Market Report 2023
Molecular Diagnostics Devices And Equipment Global Market Report 2023
Transplant Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company:
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
Global Market Model:
Found this article helpful? Share it on: